Search Results
You are looking at 1 - 4 of 4 items for
- Author: M Parvinen x
- Refine by access: All content x
Search for other papers by J. Toppari in
Google Scholar
PubMed
Search for other papers by K. K. Vihko in
Google Scholar
PubMed
Search for other papers by K. G. E. Räsänen in
Google Scholar
PubMed
Search for other papers by E. Eerola in
Google Scholar
PubMed
Search for other papers by M. Parvinen in
Google Scholar
PubMed
ABSTRACT
Plasminogen activator (PA) is secreted cyclically (in stages VII and VIII) by rat seminiferous tubules. To investigate whether this can be maintained and influenced in vitro, tubule segments from stages VI and VIII of the epithelial cycle were cultured for 3 days in chemically defined medium supplemented with testosterone, FSH, or a combination of testosterone, FSH, insulin and retinoic acid (4F).
Morphological and flow cytometric analyses of stage VI tubules suggested a roughly normal differentiation to stage VIII. They developed an increased PA secretion on day 3 of culture. Stage VIII tubules, however, did not develop all the characteristics of stage XII. Step 8 spermatids did not elongate and step 19 spermatids failed to develop into spermatozoa. Secretion of PA on day 3 was not significantly different to that on day 1. The 4F combination very significantly stimulated PA secretion in both stages, but FSH alone was effective only in stage VIII. Most of the secreted PA had a molecular weight of 43 000 in both stages, suggesting that it is of urokinase type.
The results suggest that stage VI is more able to differentiate in vitro for 3 days than stage VIII; the cyclic secretion pattern of PA was partially maintained in tubule segments from stage VI. Follicle-stimulating hormone had an effect on PA secretion only in stage VIII, whereas the 4F combination was stimulatory in both stages. The retinoic acid in this combination may be of importance in the regulation of PA secretion by seminiferous tubules.
J. Endocr. (1986) 108, 417–422
Search for other papers by A Rannikko in
Google Scholar
PubMed
Search for other papers by T-L Penttilä in
Google Scholar
PubMed
Search for other papers by F-P Zhang in
Google Scholar
PubMed
Search for other papers by J Toppari in
Google Scholar
PubMed
Search for other papers by M Parvinen in
Google Scholar
PubMed
Search for other papers by I Huhtaniemi in
Google Scholar
PubMed
Abstract
Stage-specific expression of the FSH receptor (FSHR) gene in the rat seminiferous epithelium was studied. Using transillumination-assisted microdissection for sample preparation and Northern hybridization for analysis of total RNA, we first reassessed the stage specificity of the FSHR gene expression in the adult rat testis. Sixfold higher FSHR mRNA levels were found in stages XIII–I compared with stage VI of the seminiferous epithelial cycle, which had the lowest signal level (P<0·01). The other stages had intermediate signal levels. In situ hybridization showed distribution of grains which confirmed the data obtained by Northern analysis. Prepubertal stage-specific FSHR gene expression was studied using in situ hybridization. Stage specificity could first be demonstrated at the age of 16 days when the average grain counts in stages I–IV were threefold higher than in stages VI–VII (P<0·01). The present data are in agreement with earlier findings on stage-specific FSH binding and FSHR gene expression using both microdissected and stage-synchronized seminiferous tubules. The onset of stage-specific FSHR gene expression is concomitant with maturation of the Sertoli cell population and completion of the first generation of spermatocytes. This supports the hypothesis that spermatogonia and spermatocytes may be involved in the regulation of FSHR gene expression.
Journal of Endocrinology (1996) 151, 29–35
Search for other papers by T-A Jaatinen in
Google Scholar
PubMed
Search for other papers by T-L Penttilä in
Google Scholar
PubMed
Search for other papers by A Kaipia in
Google Scholar
PubMed
Search for other papers by T Ekfors in
Google Scholar
PubMed
Search for other papers by M Parvinen in
Google Scholar
PubMed
Search for other papers by J Toppari in
Google Scholar
PubMed
Abstract
We studied the cellular distribution of inhibin α, βA and βB mRNAs in the normal human ovary and in polycystic ovarian syndrome (PCOS) by in situ hybridization. Our results show that human granulosa cells express inhibin α, βA and βB subunit mRNAs, and theca cells express inhibin α and βA subunit mRNAs. The co-localization of α and βA mRNAs in theca cells supports the hypothesis that inhibin also has an autocrine function in these cells. We did not detect any inhibin subunit mRNA in the granulosa cells of atretic follicles, while theca cells also expressed α subunit mRNA in those follicles. The present findings suggest that the expression of inhibin subunits is regulated differently in human follicular granulosa and theca cells. It has been speculated that inhibin may be involved in the development of PCOS. Our results show that the cellular localization of inhibin subunit mRNAs is not disturbed in PCOS ovaries.
Journal of Endocrinology (1994) 143, 127–137
Search for other papers by G Majdic in
Google Scholar
PubMed
Search for other papers by M Parvinen in
Google Scholar
PubMed
Search for other papers by A Bellamine in
Google Scholar
PubMed
Search for other papers by Harwood HJ Jr in
Google Scholar
PubMed
Search for other papers by WW Ku in
Google Scholar
PubMed
Search for other papers by MR Waterman in
Google Scholar
PubMed
Search for other papers by D Rozman in
Google Scholar
PubMed
Lanosterol 14alpha-demethylase (CYP51) is a cytochrome P450 enzyme involved primarily in cholesterol biosynthesis. CYP51 in the presence of NADPH-cytochrome P450 reductase converts lanosterol to follicular fluid meiosis activating sterol (FF-MAS), an intermediate of cholesterol biosynthesis which accumulates in gonads and has an additional function as oocyte meiosis-activating substance. This work shows for the first time that cholesterogenic enzymes are highly expressed only in distinct stages of spermatogenesis. CYP51, NADPH-P450 reductase (the electron transferring enzyme needed for CYP51 activity) and squalene synthase (an enzyme preceding CYP51 in the pathway) proteins have been studied. CYP51 was detected in step 3-19 spermatids, with large amounts in the cytoplasm/residual bodies of step 19 spermatids, where P450 reductase was also observed. Squalene synthase was immunodetected in step 2-15 spermatids of the rat, indicating that squalene synthase and CYP51 proteins are not equally expressed in same stages of spermatogenesis. Discordant expression of cholesterogenic genes may be a more general mechanism leading to transient accumulation of pathway intermediates in spermatogenesis. This study provides the first evidence that step 19 spermatids and residual bodies of the rat testis have the capacity to produce MAS sterols in situ.
